142 related articles for article (PubMed ID: 25982331)
1. Synthesis, and structure-activity relationship for C(4) and/or C(5) thienyl substituted pyrimidines, as a new family of antimycobacterial compounds.
Verbitskiy EV; Cheprakova EM; Slepukhin PA; Kravchenko MA; Skornyakov SN; Rusinov GL; Chupakhin ON; Charushin VN
Eur J Med Chem; 2015 Jun; 97():225-34. PubMed ID: 25982331
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antituberculosis activity of novel 5-styryl-4-(hetero)aryl-pyrimidines via combination of the Pd-catalyzed Suzuki cross-coupling and S(N)(H) reactions.
Kravchenko MA; Verbitskiy EV; Medvinskiy ID; Rusinov GL; Charushin VN
Bioorg Med Chem Lett; 2014 Jul; 24(14):3118-20. PubMed ID: 24856062
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of antitubercular activity of fluorinated 5-aryl-4-(hetero)aryl substituted pyrimidines.
Verbitskiy EV; Baskakova SA; Kravchenko MA; Skornyakov SN; Rusinov GL; Chupakhin ON; Charushin VN
Bioorg Med Chem; 2016 Aug; 24(16):3771-80. PubMed ID: 27338658
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and antimycobacterial activity of some novel imidazo[1,2-c]pyrimidines.
Chhabria MT; Jani MH
Eur J Med Chem; 2009 Oct; 44(10):3837-44. PubMed ID: 19423196
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro evaluation of substituted pyrimido[5,4-d]pyrimidines as a novel class of anti-Mycobacterium tuberculosis agents.
Bacelar AH; Carvalho MA; Proença MF
Eur J Med Chem; 2010 Jul; 45(7):3234-9. PubMed ID: 20416983
[TBL] [Abstract][Full Text] [Related]
6. Facile one-pot synthesis and antimycobacterial evaluation of pyrazolo[3,4-d]pyrimidines.
Trivedi A; Dodiya D; Surani J; Jarsania S; Mathukiya H; Ravat N; Shah V
Arch Pharm (Weinheim); 2008 Jul; 341(7):435-9. PubMed ID: 18574851
[TBL] [Abstract][Full Text] [Related]
7. A green expedient synthesis of pyridopyrimidine-2-thiones and their antitubercular activity.
Rajesh SM; Kumar RS; Libertsen LA; Perumal S; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2011 May; 21(10):3012-6. PubMed ID: 21498077
[TBL] [Abstract][Full Text] [Related]
8. Thienopyrimidines as novel inhibitors of Mycobacterium tuberculosis: synthesis and in-vitro studies.
Rashmi P; Nargund LV; Hazra K; Chandra JN
Arch Pharm (Weinheim); 2011 Jul; 344(7):459-65. PubMed ID: 21598298
[TBL] [Abstract][Full Text] [Related]
9. Facile transformation of Biginelli pyrimidin-2(1H)-ones to pyrimidines. In vitro evaluation as inhibitors of Mycobacterium tuberculosis and modulators of cytostatic activity.
Singh K; Singh K; Wan B; Franzblau S; Chibale K; Balzarini J
Eur J Med Chem; 2011 Jun; 46(6):2290-4. PubMed ID: 21450375
[TBL] [Abstract][Full Text] [Related]
10. Novel dihydropyrimidines as a potential new class of antitubercular agents.
Trivedi AR; Bhuva VR; Dholariya BH; Dodiya DK; Kataria VB; Shah VH
Bioorg Med Chem Lett; 2010 Oct; 20(20):6100-2. PubMed ID: 20813528
[TBL] [Abstract][Full Text] [Related]
11. Microwave-assisted synthesis, molecular docking and antitubercular activity of 1,2,3,4-tetrahydropyrimidine-5-carbonitrile derivatives.
Mohan SB; Ravi Kumar BV; Dinda SC; Naik D; Prabu Seenivasan S; Kumar V; Rana DN; Brahmkshatriya PS
Bioorg Med Chem Lett; 2012 Dec; 22(24):7539-42. PubMed ID: 23122523
[TBL] [Abstract][Full Text] [Related]
12. A small library of trisubstituted pyrimidines as antimalarial and antitubercular agents.
Agarwal A; Srivastava K; Puri SK; Sinha S; Chauhan PM
Bioorg Med Chem Lett; 2005 Dec; 15(23):5218-21. PubMed ID: 16171994
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of substituted 4,6-diarylpyrimidines and 3,5-diphenyl-4,5-dihydro-1H-pyrazoles as anti-tubercular agents.
Pathak V; Maurya HK; Sharma S; Srivastava KK; Gupta A
Bioorg Med Chem Lett; 2014 Jul; 24(13):2892-6. PubMed ID: 24835631
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitubercular activity of 2-(substituted phenyl/benzyl-amino)-6-(4-chlorophenyl)-5-(methoxycarbonyl)-4-methyl-3,6-dihydropyrimidin-1-ium chlorides.
Narayanaswamy VK; Nayak SK; Pillay M; Prasanna R; Coovadia YM; Odhav B
Chem Biol Drug Des; 2013 Feb; 81(2):219-27. PubMed ID: 23150983
[TBL] [Abstract][Full Text] [Related]
15. Multi-component synthesis of dihydropyrimidines by iodine catalyst at ambient temperature and in-vitro antimycobacterial activity.
Zalavadiya P; Tala S; Akbari J; Joshi H
Arch Pharm (Weinheim); 2009 Aug; 342(8):469-75. PubMed ID: 19565601
[TBL] [Abstract][Full Text] [Related]
16. Fluorinated 1,2,4-Triazolo[1,5-a]pyrimidine-6-carboxylic acid derivatives as antimycobacterial agents.
Abdel-Rahman HM; El-Koussi NA; Hassan HY
Arch Pharm (Weinheim); 2009 Feb; 342(2):94-9. PubMed ID: 19173243
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of mycobacterial replication by pyrimidines possessing various C-5 functionalities and related 2'-deoxynucleoside analogues using in vitro and in vivo models.
Srivastav NC; Rai D; Tse C; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2010 Aug; 53(16):6180-7. PubMed ID: 20718497
[TBL] [Abstract][Full Text] [Related]
18. Substituted benzyl-pyrimidines targeting thymidine monophosphate kinase of Mycobacterium tuberculosis: synthesis and in vitro anti-mycobacterial activity.
Gasse C; Douguet D; Huteau V; Marchal G; Munier-Lehmann H; Pochet S
Bioorg Med Chem; 2008 Jun; 16(11):6075-85. PubMed ID: 18467107
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antimycobacterial evaluation of various 6-substituted pyrazolo[3,4-d]pyrimidine derivatives.
Trivedi A; Vaghasiya S; Dholariya B; Dodiya D; Shah V
J Enzyme Inhib Med Chem; 2010 Dec; 25(6):893-9. PubMed ID: 21054238
[TBL] [Abstract][Full Text] [Related]
20. Development of selective DprE1 inhibitors: Design, synthesis, crystal structure and antitubercular activity of benzothiazolylpyrimidine-5-carboxamides.
Chikhale R; Menghani S; Babu R; Bansode R; Bhargavi G; Karodia N; Rajasekharan MV; Paradkar A; Khedekar P
Eur J Med Chem; 2015; 96():30-46. PubMed ID: 25874329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
